A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

Vertex Pharmaceuticals

About Vertex Pharmaceuticals:

Vertex Pharmaceuticals Incorporated is a global biotechnology company focused on the discovery, development and commercialization of breakthrough drugs for a range of serious diseases.

Vertex co-promotes with GlaxoSmithKline the new HIV protease inhibitor, Lexiva®, in the United States and Agenerase® in Europe. Vertex and Merck are collaborating on the discovery and development of Aurora kinase inhibitors, which hold the potential to play a major role for the treatment of a wide range of cancers. In North America,

Vertex's product pipeline is principally focused on viral diseases, inflammation, autoimmune diseases, and cancer.






VX-385 -- HIV infection

Merimepodib -- hepatitis C

VX-950 -- hepatitis C

VX-765 -- cytokine inhibitor of interleukin-1 beta converting enzyme (ICE)

VX-702 -- acute coronary syndromes

Pralnacasan -- inflammatory diseases

VX944, VX630 -- Cancer


More on Vertex

Home page

Key Statistics for Vertex

Basic Chart for Vertex

Analyst Opinion

Analysts Estimates


Biotech100 Index
· What are the Requirements to be listed in the Biotech100 Index?
· See the Biotech100 List

Sponsored Links

Clinical Trials
· What is a Clinical Trial?
·Phase I ,-- Phase II, -- PhaseIII
·What is Randomized Control?
 What is a Double Blind Experiment?
·What is the role of the FDA?


Key Biotech Terms


Biotech Resources


Investing in Stocks
· Small Cap Stocks
· Stocks and Bonds
· Biotech100 Index

Careers and Employment
· Biotechnology and Pharmaceutical
· What are the Fastest Growing Careers?




Copyright © 2005 BIOTECH100.COM. All rights reserved.